Speakers
Keynote/Presentation
Jack O’Meara is the CEO of Aerska, a biotech company developing RNAi medicines to address neurodegenerative diseases. Prior to founding Aerska, Jack co-founded and served as CEO of Ochre Bio, which applies advances in data science and organ perfusion to develop RNAi medicines for patients suffering from liver diseases. Between both he has raised over $100M in top tier venture capital and closed pharma partnership deals worth up to $1B. He began his career in management consulting, where he supported the global launch of Zolgensma at Novartis Gene Therapies. Jack holds technical degrees from the University of Galway in Ireland and the University of Notre Dame in the United States. His work has been featured in The Wall Street Journal, Forbes, and the Financial Times.